Randomized comparison of daily interferon alfa-2b and ribavirin for 24 weeks versus standard combination therapy for 48 weeks in veterans with chronic hepatitis C: Final results of a va multicenter study.

Published

Conference Paper

Full Text

Duke Authors

Cited Authors

  • Bini, EJ; Aytaman, A; Anand, BS; Samanta, A; Nemchausky, B; Trevino, HH; Mah'moud, MA; Weston, AP; Pimstone, NR; Stancic, S; Chang, KM; Mannix-James, R

Published Date

  • October 1, 2002

Published In

Volume / Issue

  • 36 / 4

Start / End Page

  • 581A - 581A

Published By

Pages

  • 1

International Standard Serial Number (ISSN)

  • 0270-9139

Conference Name

  • 53rd Annual Meeting of the Association-for-the-Study-of-Liver-Diseases (AASLD)

Conference Location

  • BOSTON, MASSACHUSETTS

Conference Start Date

  • November 1, 2002

Conference End Date

  • November 5, 2002